TG Therapeutics Inc (TGTX.OQ)
TGTX.OQ on NASDAQ Stock Exchange Capital Market
12.00USD
17 Jul 2018
12.00USD
17 Jul 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$12.00
$12.00
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
248,638
248,638
52-wk High
$17.30
$17.30
52-wk Low
$7.25
$7.25
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Mar '18 | 0.04 | -0.588 |
| FY 2017 | Dec '17 | 0.04 | -0.463 |
| Sep '17 | 0.04 | -0.485 | |
| Jun '17 | 0.04 | -0.448 | |
| Mar '17 | 0.04 | -0.522 | |
| FY 2016 | Dec '16 | 0.04 | -0.480 |
| Sep '16 | 0.04 | -0.505 | |
| Jun '16 | 0.04 | -0.326 | |
| Mar '16 | 0.04 | -0.283 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 5 | 0.03 | 0.04 | 0.00 | 0.04 |
| Quarter Ending Dec-18 | 5 | 0.03 | 0.04 | 0.00 | 0.04 |
| Year Ending Dec-18 | 6 | 0.11 | 0.15 | 0.00 | 3.12 |
| Year Ending Dec-19 | 6 | 21.01 | 64.20 | 0.00 | 30.22 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 6 | -0.50 | -0.41 | -0.59 | -0.39 |
| Quarter Ending Dec-18 | 6 | -0.50 | -0.39 | -0.60 | -0.40 |
| Year Ending Dec-18 | 6 | -2.06 | -1.80 | -2.36 | -1.56 |
| Year Ending Dec-19 | 6 | -1.89 | -0.73 | -2.50 | -1.42 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 214.90 | 33.15 | |
| P/E High - Last 5 Yrs. | -- | 284.62 | 47.15 | |
| P/E Low - Last 5 Yrs. | -- | 97.26 | 25.03 | |
| Beta | 1.16 | 0.76 | 0.82 | |
| Price to Sales (TTM) | 6,146.56 | 249.52 | 8.04 | |
| Price to Book (MRQ) | 10.85 | 20.91 | 4.28 | |
| Price to Tangible Book (MRQ) | 11.09 | 27.67 | 6.01 | |
| Price to Cash Flow (TTM) | -- | 128.44 | 22.37 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.36 | 1.72 | |
| Dividend Yield - 5 Year Avg | -- | 0.21 | 1.46 | |
| Dividend 5 Year Growth Rate | -- | 2.26 | -6.51 | |
| Payout Ratio(TTM) | -- | 81.45 | 47.12 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -0.26 | 33.19 | 4.77 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -0.07 | 147.62 | 12.38 | |
| Sales - 5 Yr. Growth Rate | 51.57 | 30.71 | 7.73 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -12.71 | -75.18 | 45.88 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -8.24 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 47.08 | 7.99 | |
| Capital Spending - 5 Yr. Growth Rate | 9.76 | 42.68 | 7.69 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.72 | 2.57 |
| Current Ratio (MRQ) | 3.51 | 6.59 | 3.65 |
| LT Debt to Equity (MRQ) | 0.00 | 23.42 | 13.25 |
| Total Debt to Equity (MRQ) | 0.26 | 27.63 | 17.43 |
| Interest Coverage (TTM) | -- | -152.82 | 35.13 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 56.03 | 55.10 | |
| Gross Margin - 5 Yr. Avg. | -- | 53.54 | 53.12 | |
| EBITD Margin (TTM) | -87,025.86 | -- | -- | |
| EBITD - 5 Yr. Avg | -44,177.00 | -181.32 | 15.67 | |
| Operating Margin (TTM) | -87,079.66 | -951.60 | -0.48 | |
| Operating Margin - 5 Yr. Avg. | -44,565.95 | -194.98 | 10.86 | |
| Pre-Tax Margin (TTM) | -86,853.25 | -847.04 | 1.32 | |
| Pre-Tax Margin - 5 Yr. Avg. | -44,092.01 | -199.53 | 10.99 | |
| Net Profit Margin (TTM) | -86,853.25 | -838.46 | -1.97 | |
| Net Profit Margin - 5 Yr. Avg. | -44,092.01 | -197.33 | 7.35 | |
| Effective Tax Rate (TTM) | -- | 14.88 | 20.80 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 19.11 | 24.26 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 2,031 | 23,459,372 | 746,896,227 | |
| Net Income/Employee (TTM) | -1,763,700 | -837,623 | 87,146,227 | |
| Receivable Turnover (TTM) | 2.99 | 17.81 | 5.99 | |
| Inventory Turnover (TTM) | -- | 2.84 | 3.70 | |
| Asset Turnover (TTM) | 0.00 | 0.48 | 0.88 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -108.31 | 3.13 | 10.49 | |
| Return on Assets - 5 Yr. Avg. | -92.58 | 2.92 | 11.10 | |
| Return on Investment (TTM) | -138.38 | -3.85 | 13.23 | |
| Return on Investment - 5 Yr. Avg. | -108.75 | 2.71 | 14.34 | |
| Return on Equity (TTM) | -142.02 | -5.38 | 15.27 | |
| Return on Equity - 5 Yr. Avg. | -112.40 | -3.29 | 15.70 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 0.00 | 0.00 | 51.57 |
| EPS (TTM) % | -19.62 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for TG Therapeutics Inc
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 56.45% |
| # of Holders: | 170 |
| Total Shares Held: | 44,036,852 |
| 3 Mo. Net Change: | 146,957 |
| # New Positions: | 4 |
| # Closed Positions: | 1 |
| # Increased Positions: | 10 |
| # Reduced Positions: | 3 |
| # Net Buyers: | 7 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.